Financial statements Urologia Centrum
Balance sheet data of UROLOGIA CENTRUM
|
Year
|
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
|---|---|---|---|---|---|---|---|---|
| Total assets | 543 048,90 | 756 616,97 | 747 297,63 | 797 494,68 | 733 097,63 | 297 642,53 | 302 078,99 | 299 889,95 |
| A. Fixed assets | 0,00 | 0,00 | 0,00 | 30 800,00 | 17 600,00 | 4 400,00 | 0,00 | 0,00 |
| B. Current assets | 543 048,90 | 756 616,97 | 747 297,63 | 766 694,68 | 715 497,63 | 293 242,53 | 302 078,99 | 299 889,95 |
| C. Share capital contributions (basic funds) | - | - | - | - | - | - | - | - |
| D. Own shares (stocks) | - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 543 048,90 | 756 616,97 | 747 297,63 | 797 494,68 | 733 097,63 | 297 642,53 | 302 078,99 | 299 889,95 |
| A. Equity | 157 515,76 | 153 561,90 | 165 703,20 | 166 025,17 | 168 047,02 | 175 345,02 | 192 181,48 | 219 916,47 |
| B. Liabilities and provisions for liabilities | 385 533,14 | 603 055,07 | 581 594,43 | 631 469,51 | 565 050,61 | 122 297,51 | 109 897,51 | 79 973,48 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 385 533,14 | 603 055,07 | 581 594,43 | 631 469,51 | 565 050,61 | 122 297,51 | 109 897,51 | 79 973,48 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.
AD
AD